Vacuum assisted percutaneous appliance
First Claim
1. A process for stabilizing an implanted device to create an access point in subject tissue comprising:
- placing the implanted device extending from outside the subject tissue and beneath the subject tissue in an insertion site of a subject to create the access point, the implanted device comprising;
a conduit having a bore and an outer conduit surface, where the bore has a percutaneous instrument therein and extending beyond the bore;
said percutaneous instrument comprising one of a peripherally inserted central catheter (PICC), a skeletal guide wire, a cardiac assist device line, a cannula, a Steinman pin, or Kirschner wires;
a vacuum seal or gasket between said conduit and said percutaneous instrument; and
an outer sleeve extending from above an epidermis layer of the subject tissue in the insertion site, and through to a subcutaneous layer of the subject tissue, said outer sleeve surrounding the bore and having a surface in fluid communication with the bore or the outer conduit surface of said conduit, said outer sleeve formed of a material characterized by a pore matrix having a rigidity sufficient to prevent collapse through which vacuum or hydrodynamic draw is achieved, where said implanted device further comprises;
a porous inner sleeve fluidly surrounding an outer surface of said percutaneous instrument and connected to said conduit, said porous inner sleeve configured to extend from above the epidermis layer of the subject tissue in the insertion site, and through the epidermis layer to the subcutaneous layer of the subject tissue; and
the outer sleeve being textured with pores, ridges, depressions, or indentations, at least partially surrounding said porous inner sleeve, and an intermediate matrix having a reduced pore size compared to said porous inner sleeve, said intermediate matrix between said porous inner sleeve and said outer sleeve, and where said outer sleeve and said conduit are cylindrical and are coaxial with said percutaneous instrument; and
drawing vacuum against the subject tissue at the insertion site in subject tissue through said outer sleeve and said conduit for a sufficient amount of time to draw fibroblasts into and onto said outer sleeve to stabilize the implanted device in the subject tissue at the insert site, where once stabilized the implanted device is capable of being kept in place as long as for weeks or months.
2 Assignments
0 Petitions
Accused Products
Abstract
A device for reducing agent penetration at an insertion site is provided that has a porous inner sleeve fluidly connected to a conduit. A vacuum or hydrodynamic source is fluidly connected to the conduit. The device is stabilized by fibroblast in-growth and inhibits bacterial colonization. A device is also provided that has a conduit having a bore and an outer conduit surface. The outer conduit surface is optionally nanotextured to promote fibroblast adhesion and limit bacterial residency. A sleeve is provided in fluid communication with the bore of the conduit, and is formed from materials characterized by a pore matrix through which vacuum or hydrodynamic draw is achieved in a process to promote stabilization and reducing bacterial colonization by draw fluid from an area around the surrounding the site of the device. The sleeve optionally has a distal nanotextured surface.
86 Citations
9 Claims
-
1. A process for stabilizing an implanted device to create an access point in subject tissue comprising:
-
placing the implanted device extending from outside the subject tissue and beneath the subject tissue in an insertion site of a subject to create the access point, the implanted device comprising;
a conduit having a bore and an outer conduit surface, where the bore has a percutaneous instrument therein and extending beyond the bore;
said percutaneous instrument comprising one of a peripherally inserted central catheter (PICC), a skeletal guide wire, a cardiac assist device line, a cannula, a Steinman pin, or Kirschner wires;
a vacuum seal or gasket between said conduit and said percutaneous instrument; and
an outer sleeve extending from above an epidermis layer of the subject tissue in the insertion site, and through to a subcutaneous layer of the subject tissue, said outer sleeve surrounding the bore and having a surface in fluid communication with the bore or the outer conduit surface of said conduit, said outer sleeve formed of a material characterized by a pore matrix having a rigidity sufficient to prevent collapse through which vacuum or hydrodynamic draw is achieved, where said implanted device further comprises;
a porous inner sleeve fluidly surrounding an outer surface of said percutaneous instrument and connected to said conduit, said porous inner sleeve configured to extend from above the epidermis layer of the subject tissue in the insertion site, and through the epidermis layer to the subcutaneous layer of the subject tissue; and
the outer sleeve being textured with pores, ridges, depressions, or indentations, at least partially surrounding said porous inner sleeve, and an intermediate matrix having a reduced pore size compared to said porous inner sleeve, said intermediate matrix between said porous inner sleeve and said outer sleeve, and where said outer sleeve and said conduit are cylindrical and are coaxial with said percutaneous instrument; anddrawing vacuum against the subject tissue at the insertion site in subject tissue through said outer sleeve and said conduit for a sufficient amount of time to draw fibroblasts into and onto said outer sleeve to stabilize the implanted device in the subject tissue at the insert site, where once stabilized the implanted device is capable of being kept in place as long as for weeks or months. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
Specification